Research at Baptist Health Hardin

Medical research represents the future of healthcare. That is why Baptist Health hospitals participate in clinical research projects. This participation is a key part of our organization-wide commitment to improving medical outcomes for patients both today and tomorrow. Baptist Health Hardin is committed to providing its patients with the best care possible. To fulfill this goal, we offer opportunities to participate in clinical trials in addition to standard medical treatments. These trials range from observational studies, where we collect data regarding particular conditions or diseases, to treatment trials in which examine the safety and effectiveness of new drugs or therapies in managing your health condition.  At Baptist Health Hardin we offer clinical trials in cancer care and cardiac care.


Current Research

Below is a list of clinical trials currently underway at Baptist Health Paducah:

Cancer Care:

  • NRG-LU005: A Phase II/III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab
  • LungMap: A Master Protocol to Evaluate Biomarker-Driven Therapies and Immunotherapies in Previously-Treated Non-Small Cell Lung Cancer
  • A151216: Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
  • Pacific 4: A Phase III, Randomized, Placebo-controlled, Double-blind, Multi-center, International Study of Durvalumab with Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Patients with unresected Stage I/II, lymph-node
  • VastBiome: The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
  • Ascend 2: Detecting Cancers Earlier Through Elective Plasma-Based CancerSEEK Testing-Ascertaining Serial Cancer Patients to Enable New Diagnostic II (DETECT-ASCEND 2)

Cardiac Care:

  • Stride 4533: Effects of semaglutide on functional capacity in patients with type 2 diabetes and peripheral arterial disease
  • Care HK: Cardiovascular and Renal Treatment in Heart Failure Patients with Hyperkalemia or at High Risk of Hyperkalemia (CARE-HK in HF Registry)

A Team Approach to Research

Research is a team effort. The research team at Baptist Health Hardin is always on the lookout for groundbreaking clinical trials that offer new hope to patients living with certain medical conditions. We have several ongoing studies that target different types and stages of cancer and cardiac care, focusing on those with an emphasis on those most prevalent in our region. Our research staff identifies and screens patients on a daily basis to provide them with treatment options that go beyond standard levels of care.

Research as Resource

The Baptist Health Hardin research team offers a number of services that are vital to the success of clinical research and testing:

  • Participation in federal and commercially sponsored trials that provide new treatment opportunities for various medical conditions and diseases 
  • Research coordination 
  • Trial-matching patients to studies taking place both inside and outside Baptist Health 
  • Collaboration with other hospitals and treatment centers to find the best possible fit between patients and research initiatives.

Areas of Emphasis

The Baptist Health Hardin research program focuses on studying and treating cancer and cardiac related illnesses. We are currently undertaking a range of commercially and federally sponsored trials in the areas of lung, breast cancer and cardiac care.


How to Contact Us

For general questions about the research program at Baptist Health Hardin, please contact our clinical research manager:

Melissa Barnes
Manager, Research Regulatory
Phone: 859.260.6363
Email: melissa.barnes2@bhsi.com

If you are currently participating in a trial and have a question, please contact your study coordinator, your physician, or the physician overseeing your study. Contact information was included with the consent documents you signed when you enrolled in the trial.


Where We’re Located

Baptist Health Hardin Research Department
521 Robinbrooke Blvd

Elizabethtown, KY 42701